Stifel Nicolaus Downgrades BioMed Realty (BMR) to Hold
More News related to BMR
- Bradmer announces 2008 second quarter operational and financial results
- Wachovia Downgrades BioMed Realty Trust (BMR) to Market Perform
- BioMed Realty Trust (BMR) Reports Q2 FFO of $0.47
- BioMed Realty Trust Reports Second Quarter 2008 Financial Results
- Bradmer initiates enrollment in Phase III GLASS-ART Trial in primary glioblastoma multiforme
Stifel Nicolaus downgrades BioMed Realty (NYSE: BMR) from Buy to Hold.
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry.
Related Categories
DowngradesStocks Mentioned
-0.47Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
